GlassScriptPhysician profile
Martand Chhibber
NPI 1184121717
$2,695.18
in general payments reported to CMS, 2019-2025
11 companies · $119 in 2025
The $119 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,919 · 2024: $657 · 2025: $119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $776.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $776.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,919.15 | 2022 | |
| Boston Scientific Corporation | $237.51 | 2024 | Wavewriter Alpha Prime 16 |
| Collegium Pharmaceutical, INC. | $202.33 | 2024-2025 | Belbuca, Xtampza |
| Pfizer INC. | $131.80 | 2024-2025 | |
| Scilex Pharmaceuticals INC. | $48.09 | 2024 | |
| Idorsia Pharmaceuticals US INC | $31.34 | 2024 | Quviviq |
| Abbvie INC. | $30.75 | 2024 | |
| Valinor Pharma, LLC | $24.81 | 2025 | Movantik |
| Vertos Medical, INC. | $23.70 | 2024 | Mild Device Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $23.28 | 2025 | Trintellix |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.42 | 2024 | Relistor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Martand Chhibber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.